Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
McGovern Capital is a global investment and advisory firm that specializes in the formation, funding, and management of companies, with a significant focus on life sciences, healthcare, and environmental technologies. Founded by Kevin McGovern, the firm operates as a "company builder," having co-founded or played a primary role in over 25 companies worldwide. Their expertise lies in identifying and commercializing breakthrough intellectual property, particularly in medical devices, consumer health, and biotechnology. The firm provides strategic guidance, capital, and operational support to help early-stage ventures scale globally. McGovern Capital is well-regarded for its ability to bridge the gap between innovative research and commercial success, maintaining strong ties to academic institutions and global corporations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on McGovern Capital.